Hansa Biopharma — Juni 2024
-
Enig exitnu...Det samtidigt med, at aktien kører under radaren hos mange investorer efter det voldsomme fald i kursen de senere år.
-
Hansa Biopharma ska presentera flera abstrakt kring imlifidase vid ATC-kongress
"Hansa Biopharma kommer att presentera sina abstrakt mellan den 2-5 juni."
(21 maj 2024)
I aften dansk tid og frem ....
-
Aktierna som hela analytikerkåren gör tummen upp för https://www.borskollen.se/nyheter/27/aktierna-som-hela-analytikerkaren-gor-tummen-upp-for
-
Stadig faldende tendens for shortandelen. https://www.borskollen.se/aktie/hansa-biopharma
-
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Sarepta stock jumped Thursday after Pfizer's rival gene therapy for Duchenne muscular dystrophy failed in final-phase testing.
Yahoo Finance (finance.yahoo.com)
Sarepta stock jumped Thursday after Pfizer's (PFE) rival gene therapy for Duchenne muscular dystrophy failed in final-phase testing.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind